{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Arrowhead Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"ARWR"},"Address":{"label":"Address","value":"177 E. COLORADO BOULEVARD SUITE 700, PASADENA, California, 91105, United States"},"Phone":{"label":"Phone","value":"+1 626 304-3400"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.arrowheadpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher Richard Anzalone","title":"President, Chief Executive Officer &amp; Director"},{"name":"Javier San Martin","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}